Market Closed -
Bombay S.E.
11:00:49 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
539.4
INR
|
-2.76%
|
|
-4.36%
|
-2.47%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
841.4
|
1,177
|
1,447
|
2,584
|
2,659
|
3,930
|
Enterprise Value (EV)
1 |
736.5
|
1,028
|
1,142
|
2,271
|
2,268
|
3,672
|
P/E ratio
|
11.9
x
|
8.96
x
|
6.03
x
|
12.3
x
|
15.9
x
|
9.39
x
|
Yield
|
2.91%
|
4.16%
|
5.41%
|
1.89%
|
1.1%
|
1.49%
|
Capitalization / Revenue
|
2.19
x
|
2.49
x
|
2.09
x
|
4.11
x
|
4.02
x
|
3.55
x
|
EV / Revenue
|
1.92
x
|
2.17
x
|
1.65
x
|
3.62
x
|
3.43
x
|
3.31
x
|
EV / EBITDA
|
6.36
x
|
5.42
x
|
2.87
x
|
8.59
x
|
10.2
x
|
6.59
x
|
EV / FCF
|
3.92
x
|
13
x
|
5.89
x
|
197
x
|
21.5
x
|
-38.9
x
|
FCF Yield
|
25.5%
|
7.71%
|
17%
|
0.51%
|
4.65%
|
-2.57%
|
Price to Book
|
1.97
x
|
2.41
x
|
2.22
x
|
3.04
x
|
2.65
x
|
2.92
x
|
Nbr of stocks (in thousands)
|
9,783
|
9,783
|
9,783
|
9,783
|
9,783
|
9,783
|
Reference price
2 |
86.00
|
120.3
|
147.9
|
264.2
|
271.8
|
401.7
|
Announcement Date
|
26/07/18
|
13/07/19
|
08/08/20
|
25/06/21
|
01/06/22
|
25/05/23
|
Fiscal Period: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
384.4
|
473.2
|
693
|
628.2
|
661.1
|
1,108
|
EBITDA
1 |
115.8
|
189.7
|
398
|
264.4
|
222.6
|
557
|
EBIT
1 |
96.33
|
169.6
|
377.7
|
246.6
|
207
|
540.9
|
Operating Margin
|
25.06%
|
35.85%
|
54.5%
|
39.26%
|
31.32%
|
48.82%
|
Earnings before Tax (EBT)
1 |
82.39
|
178.2
|
351.7
|
258.1
|
221
|
563.5
|
Net income
1 |
70.89
|
131.3
|
239.9
|
209.9
|
167.1
|
419
|
Net margin
|
18.44%
|
27.75%
|
34.61%
|
33.42%
|
25.28%
|
37.82%
|
EPS
2 |
7.246
|
13.42
|
24.52
|
21.46
|
17.08
|
42.80
|
Free Cash Flow
1 |
187.7
|
79.19
|
193.9
|
11.55
|
105.5
|
-94.46
|
FCF margin
|
48.83%
|
16.74%
|
27.98%
|
1.84%
|
15.96%
|
-8.53%
|
FCF Conversion (EBITDA)
|
162.07%
|
41.74%
|
48.73%
|
4.37%
|
47.4%
|
-
|
FCF Conversion (Net income)
|
264.78%
|
60.3%
|
80.84%
|
5.5%
|
63.13%
|
-
|
Dividend per Share
2 |
2.500
|
5.000
|
8.000
|
5.000
|
3.000
|
6.000
|
Announcement Date
|
26/07/18
|
13/07/19
|
08/08/20
|
25/06/21
|
01/06/22
|
25/05/23
|
Fiscal Period: Marzo |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
105
|
149
|
305
|
313
|
391
|
258
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
188
|
79.2
|
194
|
11.6
|
106
|
-94.5
|
ROE (net income / shareholders' equity)
|
17.7%
|
28.7%
|
42.1%
|
28%
|
18.1%
|
35.7%
|
ROA (Net income/ Total Assets)
|
11.3%
|
18.5%
|
34.1%
|
18%
|
12.6%
|
25.8%
|
Assets
1 |
627.9
|
709.6
|
702.4
|
1,165
|
1,326
|
1,622
|
Book Value Per Share
2 |
43.60
|
49.90
|
66.60
|
86.90
|
102.0
|
138.0
|
Cash Flow per Share
2 |
0.4900
|
0
|
3.830
|
0.5100
|
1.030
|
2.670
|
Capex
1 |
9.48
|
26.4
|
30.2
|
113
|
150
|
233
|
Capex / Sales
|
2.47%
|
5.58%
|
4.35%
|
18.01%
|
22.65%
|
21.02%
|
Announcement Date
|
26/07/18
|
13/07/19
|
08/08/20
|
25/06/21
|
01/06/22
|
25/05/23
|
|
1st Jan change
|
Capi.
|
---|
| -2.47% | 65.03M | | +6.15% | 105B | | -4.19% | 65.16B | | +51.90% | 42.93B | | +17.59% | 39.48B | | +7.38% | 33.27B | | +12.20% | 19.92B | | +16.25% | 17.49B | | +20.35% | 15.43B | | +9.86% | 15.09B |
Other Commodity Chemicals
|